New Age Alpha Advisors, LLC Biomarin Pharmaceutical Inc Transaction History
New Age Alpha Advisors, LLC
- $2.47 Trillion
- Q4 2024
A detailed history of New Age Alpha Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 23,422 shares of BMRN stock, worth $1.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
23,422Holding current value
$1.6 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.55 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.32 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.24 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.01 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$887 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.7B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...